| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acquisition of Signaling and ETV6 Mutations is Associated With Transformation to CMML
|
Padron, Eric
|
|
2014
|
14 |
S |
p. S153-S154
2 p.
|
artikel
|
| 2 |
Acute Myeloid Leukemia Cells Acquire Stem Cell Features in the Bone Marrow Microenvironment
|
Battula, V. Lokesh
|
|
2014
|
14 |
S |
p. S119-S120
2 p.
|
artikel
|
| 3 |
Allogeneic Stem Cell Transplant vs. Janus Kinase Inhibition in the Treatment of Primary Myelofibrosis or Myelofibrosis After Essential Thrombocythemia or Polycythemia Vera
|
Alchalby, Haefaa
|
|
2014
|
14 |
S |
p. S36-S41
6 p.
|
artikel
|
| 4 |
An Integrated Efficacy and Safety Analysis of Phase 1/2 Studies of Tosedostat, a Novel Aminopeptidase Inhibitor, as Monotherapy for Hematological Malignancies
|
Myint, Han
|
|
2014
|
14 |
S |
p. S124-S125
2 p.
|
artikel
|
| 5 |
Antiproliferative and Proapoptotic Effects of Topotecan in Combination With Thymoquinone on Acute Myelogenous Leukemia
|
Khalife, Rana
|
|
2014
|
14 |
S |
p. S46-S55
10 p.
|
artikel
|
| 6 |
A Phase II Expansion Study of Vorinostat in Combination With Idarubicin and Cytarabine for Patients With Acute Myelogenous Leukemia (AML) With FLT3 Molecular Alterations
|
Takahashi, Koichi
|
|
2014
|
14 |
S |
p. S123-
1 p.
|
artikel
|
| 7 |
A Pilot Study of Mitoxantrone in Combination With Clofarabine (MITCL) in Children, Adolescents and Young Adults (CAYA) With Refractory/Relapsed Acute Leukemia or High Grade Non-Hodgkin Lymphoma
|
Hochberg, Jessica
|
|
2014
|
14 |
S |
p. S115-
1 p.
|
artikel
|
| 8 |
A Previously Unknown Pro-apoptotic Effect of STAT3 in CLL Cells of High Count CLL
|
Rozovski, Uri
|
|
2014
|
14 |
S |
p. S133-S134
2 p.
|
artikel
|
| 9 |
Asparaginase in Acute Lymphoblastic Leukemia
|
Kawedia, Jitesh D.
|
|
2014
|
14 |
S |
p. S14-S17
4 p.
|
artikel
|
| 10 |
Asymptomatic Monoclonal Gammopathies
|
Bories, Claire
|
|
2014
|
14 |
S |
p. S78-S86
9 p.
|
artikel
|
| 11 |
BAALC-associated miR-3151 is an Independent Prognostic Factor in Young Patients With Intermediate-Risk Cytogenetic Acute Myeloid Leukemia
|
Díaz-Beyá, M.
|
|
2014
|
14 |
S |
p. S122-S123
2 p.
|
artikel
|
| 12 |
Biological and Clinical Implications of Exon 8 P53 (R282W) Gene Mutation in Relation to Development and Progression of Chronic Myeloid Leukemia Patients in India Population
|
Guru, Sameer
|
|
2014
|
14 |
S |
p. S140-
1 p.
|
artikel
|
| 13 |
Biology and Treatment of Myeloma
|
Brioli, Annamaria
|
|
2014
|
14 |
S |
p. S65-S70
6 p.
|
artikel
|
| 14 |
Bone Marrow (BM) May be More Informative Than Peripheral Blood (PB) to Evaluate Minimal Residual Disease (MRD) During 1st and 2nd Year Follow up After First-line Fludarabine, Cyclophosphamide, and Rituximab (FCR) for Chronic Lymphocytic Leukemia (CLL)
|
Strati, Paolo
|
|
2014
|
14 |
S |
p. S134-S135
2 p.
|
artikel
|
| 15 |
CD99 Identifies Disease Stem Cells in Acute Myeloid Leukemia (AML) and the Myelodysplastic Syndromes (MDS)
|
Chung, Stephen S.
|
|
2014
|
14 |
S |
p. S121-
1 p.
|
artikel
|
| 16 |
Chk1 and WEE1 Inhibition Combine Synergistically and Represent a Novel Non-cytotoxic Combination in Acute Myeloid Leukemia
|
Tibes, Raoul
|
|
2014
|
14 |
S |
p. S127-S128
2 p.
|
artikel
|
| 17 |
Clinical and Biologic Effects of the Angiopoietin 1/2 Neutralizing Peptibody Trebananib (AMG 386) in Acute Myeloid Leukemia Patients
|
S, Wang Eunice
|
|
2014
|
14 |
S |
p. S126-
1 p.
|
artikel
|
| 18 |
Clinical Implications of the SETBP1 Mutation in Patients With Primary Myelodysplastic Syndrome and its Stability During Disease Progression
|
Hou, H.A.
|
|
2014
|
14 |
S |
p. S153-
1 p.
|
artikel
|
| 19 |
Clinical Significance of del11q FISH% in Patients With Chronic Lymphocytic Leukemia (CLL) – Can it Impact Prognostication in the Routine Clinical Practice? – Comprehensive Analysis From MD Anderson Cancer Center
|
Jain, Preetesh
|
|
2014
|
14 |
S |
p. S131-S132
2 p.
|
artikel
|
| 20 |
Clonal Heterogeneity and Evolution of Acute Myeloid Leukemia During Disease Progression
|
Kihara, Rika
|
|
2014
|
14 |
S |
p. S124-
1 p.
|
artikel
|
| 21 |
Combined Targeting of Mcl-1 With TG02 and Bcl-2 With ABT-199/ABT-737 for Treatment of Hematologic Malignancies
|
Burrows, Francis
|
|
2014
|
14 |
S |
p. S152-
1 p.
|
artikel
|
| 22 |
Continuing Medical Education Post-Test [Course Code: E111690]
|
|
|
2014
|
14 |
S |
p. S160-S163
4 p.
|
artikel
|
| 23 |
Detection of Lymphoid and Myeloid Lineages in Infantile B Acute Lymphoblastic Leukemia With Mixed Lineage Leukemia Rearrangement by Use of Flow Cytometry and Cytogenetics
|
Gaikwad, Amos
|
|
2014
|
14 |
S |
p. S114-S115
2 p.
|
artikel
|
| 24 |
Detection of Lymphoid and Myeloid Lineages in Infantile B-Cell Acute Lymphoblastic Leukemia With Mixed-Lineage Leukemia Rearrangement by Use of Flow Cytometry and Cytogenetic Analysis
|
Gaikwad, Amos
|
|
2014
|
14 |
S |
p. S2-S5
4 p.
|
artikel
|
| 25 |
Early Blast Phase Transformation In Chronic Phase Chronic Myeloid Leukemia: Is Flow Cytometry The Missing Link?
|
El Rassi, Fuad
|
|
2014
|
14 |
S |
p. S136-S137
2 p.
|
artikel
|
| 26 |
Editorial Board/Masthead
|
|
|
2014
|
14 |
S |
p. A6-
1 p.
|
artikel
|
| 27 |
Effect of Radiotherapy on the Survival of Patients With Stage I and Stage II Mantle Cell Lymphoma: Analysis of the Surveillance, Epidemiology and End Results Database
|
Guru Murthy, Guru Subramanian
|
|
2014
|
14 |
S |
p. S90-S95
6 p.
|
artikel
|
| 28 |
Efficacy, Safety and Responder Subanalysis of Lenalidomide in Heavily Pretreated, Relapsed/Refractory Patients With Mantle Cell Lymphoma Post-Bortezomib: Phase II MCL-001 “EMERGE” Study
|
Goy, Andre
|
|
2014
|
14 |
S |
p. S141-S142
2 p.
|
artikel
|
| 29 |
Efficient Identification of Response to Cytarabine Idarubicin in Newly Diagnosed Acute Myeloid Leukemia by a New Individualized Medicine Test Based on ex vivo Pharmacology
|
Montesinos, Pau
|
|
2014
|
14 |
S |
p. S118-S119
2 p.
|
artikel
|
| 30 |
Epigenetic Silencing of P16 (INK4a) Gene by Promoter Hypermethylation in Chronic Myelogenous Leukemia
|
Ahmad, Imtiyaz
|
|
2014
|
14 |
S |
p. S139-
1 p.
|
artikel
|
| 31 |
Exposure to Decitabine (Dac), Both In Vitro and in Peripheral Blood Blasts From Acute Myeloid Leukemia (AML) Patients, Enhances the Expression of CD58 and Antigen Presentation Machinery on Leukemic Cells
|
Paluch, BE
|
|
2014
|
14 |
S |
p. S125-
1 p.
|
artikel
|
| 32 |
Expression of Constitutively Activated NF-κB/mTORC Pathway Proteins and Response to CHOP With Bortezomib in a Patient With Angioimmunoblastic Peripheral T-Cell Lymphoma
|
Quesada, Andrés E.
|
|
2014
|
14 |
S |
p. S87-S89
3 p.
|
artikel
|
| 33 |
Expression of NFκB/mTORC Pathway Proteins is Associated With Response to CHOP plus Bortezomib (CHOP-B) in a Patient With Angioimmunoblastic Peripheral T-cell Lymphoma (AI-PTCL)
|
Quesada, Andres E.
|
|
2014
|
14 |
S |
p. S145-
1 p.
|
artikel
|
| 34 |
Healthcare Resource Utilization (HRU) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
|
Kozma, Chris
|
|
2014
|
14 |
S |
p. S132-
1 p.
|
artikel
|
| 35 |
HIV-Related Hematological Malignancies: A Concise Review
|
Rios, Adan
|
|
2014
|
14 |
S |
p. S96-S103
8 p.
|
artikel
|
| 36 |
Hodgkin Transformation of Chronic Lymphocytic Leukemia (CLL): Mayo Clinic Experience
|
Parikh, Sameer A.
|
|
2014
|
14 |
S |
p. S132-S133
2 p.
|
artikel
|
| 37 |
Human Multipotent Adult Progenitor Cells Effectively Reduce GVHD While Preserving Graft-Versus-Leukemia Activity after Allogeneic BMT
|
Metheny, Leland
|
|
2014
|
14 |
S |
p. S158-
1 p.
|
artikel
|
| 38 |
Humoral and Cellular Immunotherapy in ALL in Children, Adolescents, and Young Adults
|
Hochberg, Jessica
|
|
2014
|
14 |
S |
p. S6-S13
8 p.
|
artikel
|
| 39 |
Identification and Characterization of Novel Fusion Proteins in Pediatric Acute Megakaryoblastic Leukemia
|
Dang, Jinjun
|
|
2014
|
14 |
S |
p. S123-S124
2 p.
|
artikel
|
| 40 |
Impact of Baseline Mutations on Response to Ponatinib and End of Treatment Mutation Analysis in Patients With Chronic Myeloid Leukemia
|
Deininger, Michael W.
|
|
2014
|
14 |
S |
p. S136-
1 p.
|
artikel
|
| 41 |
Impact of Radiotherapy on Survival of Patients With Limited Stage Mantle Cell Lymphoma - Analysis of Surveillance Epidemiology and End Results Database
|
Guru Murthy, Guru Subramanian
|
|
2014
|
14 |
S |
p. S142-S143
2 p.
|
artikel
|
| 42 |
Inactivation of RIZ1 Gene by RIZ1 Pro704 Insertion–Deletion Polymorphism and Promoter Hypermethylation is Associated With Disease Progression and Resistance to Imatinib in Indian Chronic Myelogenous Leukemia Patients
|
Mir, Rashid
|
|
2014
|
14 |
S |
p. S140-
1 p.
|
artikel
|
| 43 |
Infection Control Practices in Patients With Hematological Malignancies and Multidrug-Resistant Organisms: Special Considerations and Challenges
|
Ariza-Heredia, Ella J.
|
|
2014
|
14 |
S |
p. S104-S110
7 p.
|
artikel
|
| 44 |
Initial Clinico-Biological Characteristics and Follow-up Data of Elderly Patients With Chronic Lymphocytic Leukemia (CLL): A Retrospective Analysis of a Series of 364 Cases
|
Baumann, Tycho
|
|
2014
|
14 |
S |
p. S129-S130
2 p.
|
artikel
|
| 45 |
Lessons From the Treatment for Childhood Acute Lymphoblastic Leukemia (ALL) in Taiwan
|
Liang, D.-C.
|
|
2014
|
14 |
S |
p. S115-S116
2 p.
|
artikel
|
| 46 |
Long-Term Effects of Ruxolitinib on Bone Marrow Morphology in Patients With Myelofibrosis and Comparison to Best Available Therapy
|
Kvasnicka, Hans Michael
|
|
2014
|
14 |
S |
p. S155-
1 p.
|
artikel
|
| 47 |
Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP)
|
Strati, Paolo
|
|
2014
|
14 |
S |
p. S145-S146
2 p.
|
artikel
|
| 48 |
Lower Expression of miR-181 and miR-331 is an Independent Poor Prognostic Factor in Acute Myeloid Leukemia (AML) Patients
|
Chuang, Ming-Kai
|
|
2014
|
14 |
S |
p. S120-S121
2 p.
|
artikel
|
| 49 |
MicroRNA Gene Transcription is Regulated by STAT3 in Chronic Lymphocytic Leukemia (CLL) Cells
|
Rozovski, Uri
|
|
2014
|
14 |
S |
p. S133-
1 p.
|
artikel
|
| 50 |
miR-3151 Interplays With its Host Gene BAALC and Independently Impacts on Outcome of Older Patients With Cytogenetically Normal Acute Myeloid Leukemia by Direct Deregulation of TP53
|
Eisfeld, Ann-Kathrin
|
|
2014
|
14 |
S |
p. S157-
1 p.
|
artikel
|
| 51 |
Modified SMILE (mSMILE) is Active in the Treatment of Extranodal Natural Killer/T-Cell Lymphoma: A Single Center US Experience
|
M, Lunning
|
|
2014
|
14 |
S |
p. S143-S144
2 p.
|
artikel
|
| 52 |
Molecular Responses at 3 and 6 Months Predict Outcomes in Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Front-line Imatinib: Taiwan CML Study Group
|
Kuo, Ming-Chung
|
|
2014
|
14 |
S |
p. S138-
1 p.
|
artikel
|
| 53 |
Multiple Myeloma and Plasmactyoma-Like Post-Transplant Lymphoproliferative Disorders (PTLD): Examination of Outcomes and Prognostication in the Modern Era
|
Rosenberg, Aaron
|
|
2014
|
14 |
S |
p. S148-S150
3 p.
|
artikel
|
| 54 |
Myeloproliferative Neoplasms: JAK2 Signaling Pathway as a Central Target for Therapy
|
Pasquier, Florence
|
|
2014
|
14 |
S |
p. S23-S35
13 p.
|
artikel
|
| 55 |
Nilotinib or Dasatinib Front-Line Therapy in Patients (Pts) With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia (CML-CP) With Pre-existing Liver and/or Renal dysfunction
|
Sasaki, Koji
|
|
2014
|
14 |
S |
p. S138-S139
2 p.
|
artikel
|
| 56 |
Novel Drug Combinations for the Management of Relapsed/Refractory Multiple Myeloma
|
Usmani, Saad Z.
|
|
2014
|
14 |
S |
p. S71-S77
7 p.
|
artikel
|
| 57 |
25(OH) Vitamin D3 Delays Leukemogenesis in an Acute Myeloid Leukemia Murine Model
|
Den Haese, Jason P.
|
|
2014
|
14 |
S |
p. S121-S122
2 p.
|
artikel
|
| 58 |
“One-Size-Fits-All” Cellular Therapy for Hematology Patients: How Much Overconsumption?
|
Cano, Pedro
|
|
2014
|
14 |
S |
p. S116-
1 p.
|
artikel
|
| 59 |
Outcome of Chronic Lymphocytic Leukemia (CLL) Patients That Failed Allogeneic Stem Cell Transplantation
|
Benjamini, Ohad
|
|
2014
|
14 |
S |
p. S130-S131
2 p.
|
artikel
|
| 60 |
Patients With Newly Diagnosed Multiple Myeloma and Chromosome 1 Amplification Have Inferior Progression Free Survival and Early Onset Extramedullary/CNS Disease, Despite the Use of Novel Triplet Regimens
|
Biran, Noa
|
|
2014
|
14 |
S |
p. S150-
1 p.
|
artikel
|
| 61 |
Pegfilgrastim for Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma Undergoing Dose Adjusted-EPOCH-R: The MSKCC Experience
|
M.A., Lunning
|
|
2014
|
14 |
S |
p. S144-
1 p.
|
artikel
|
| 62 |
Phenotypic and Genotypic Profiling of MDM2, Respective to the TP53 Genetic Status, in Diffuse Large B-cell Lymphoma Patients Treated With Rituximab-CHOP Immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium Program
|
Xu-Monette, Zijun Y.
|
|
2014
|
14 |
S |
p. S146-S147
2 p.
|
artikel
|
| 63 |
Pilot Study of Regulatory T Cell Depletion In The Setting Of Autologous Stem Cell Transplantation For Multiple Myeloma
|
von Keudell, Gottfried
|
|
2014
|
14 |
S |
p. S150-S152
3 p.
|
artikel
|
| 64 |
Pilot Study on Thiamine Deficiency in Stem Cell Transplant Patients Prompted by Altered Mental Status due to Wernicke’s Encephalopathy in ALL Transplant Patient
|
Steinberg, Amir
|
|
2014
|
14 |
S |
p. S158-S159
2 p.
|
artikel
|
| 65 |
Prevalence and Clinical Implications of Epstein-Barr Virus Infection in de novo Diffuse Large B-Cell Lymphoma in Western Countries: A report from The International DLBCL Rituximab-CHOP Consortium Program
|
Ok, Chi Young
|
|
2014
|
14 |
S |
p. S144-S145
2 p.
|
artikel
|
| 66 |
Primacy of Resistance Rather Than Toxicity in Determining Outcome of Therapy for AML
|
Estey, Elihu H.
|
|
2014
|
14 |
S |
p. S56-S58
3 p.
|
artikel
|
| 67 |
Primary Effusion Lymphoma in elderly Patient Effectively Treated by Lenalidomide
|
Antar, Ahmad
|
|
2014
|
14 |
S |
p. S141-
1 p.
|
artikel
|
| 68 |
Prognostic Significance of Quantifying Circulating Plasma Cells in Multiple Myeloma
|
Gonsalves, Wilson I.
|
|
2014
|
14 |
S |
p. S147-
1 p.
|
artikel
|
| 69 |
Progress in Novel Cellular Therapy Options for Chronic Lymphocytic Leukemia: The MD Anderson Perspective
|
Shah, Nina
|
|
2014
|
14 |
S |
p. S18-S22
5 p.
|
artikel
|
| 70 |
Prolonged Remission of FLT3-ITD Positive AML Treated With Sorafenib Post Allogeneic Stem Cell Transplantation
|
Moukadem, Hiba
|
|
2014
|
14 |
S |
p. S126-S127
2 p.
|
artikel
|
| 71 |
Putting the ‘Activate’ in Activated B Cell-like Diffuse Large B Cell Lymphoma: A Role for the Noncanonical NF-κB Pathway
|
Koff, Jean L.
|
|
2014
|
14 |
S |
p. S143-
1 p.
|
artikel
|
| 72 |
Safety and Durability of Ponatinib in Patients With Philadelphia Chromosome–Positive (Ph+) Leukemia: Long-term Follow-up of an Ongoing Phase 1 Study
|
Mauro, Michael J.
|
|
2014
|
14 |
S |
p. S137-S138
2 p.
|
artikel
|
| 73 |
Should Patients With High-Risk or Transformed Myelodysplastic Syndrome Proceed Directly to Allogeneic Transplant Without Prior Cytoreduction by Remission-Induction Chemotherapy or Hypomethylating Agent Therapy?
|
de Witte, Theo M.
|
|
2014
|
14 |
S |
p. S42-S45
4 p.
|
artikel
|
| 74 |
Significant Improvement in Quality of Life (QoL) in Patients With Chronic Myeloproliferative Neoplasms (CMPN) and Myelofibrosis Treated With JAK-1 and JAK-2 Inhibitor Ruxolitinib
|
Vargas-Viveros, Pablo
|
|
2014
|
14 |
S |
p. S155-S156
2 p.
|
artikel
|
| 75 |
Single Nucleotide Polymorphisms in IKZF1, ARID5B and CEBPE are a Risk Factor for the Development of Adult ALL
|
Burmeister, Thomas
|
|
2014
|
14 |
S |
p. S114-
1 p.
|
artikel
|
| 76 |
STAT3-induced GM-CSFRα Protects Chronic Lymphocytic Leukemia (CLL) Cells From Apoptosis
|
Rozovski, Uri
|
|
2014
|
14 |
S |
p. S134-
1 p.
|
artikel
|
| 77 |
1st Line AML Equivalent Treatments Cytarabine Plus an Anthracyclin (Ida, Dau, Mit) Show Alternative Sensitive/Resistant Profiles in ex vivo Patient Sample Chemosensitivity; Could Personalizing be the Key Selection Criterion?
|
Montesinos, Pau
|
|
2014
|
14 |
S |
p. S117-S118
2 p.
|
artikel
|
| 78 |
Survival Outcomes in Relapsed/Refractory Acute Myeloid Leukemia Patients Who Achieve Less-than-Complete Response After First Salvage Therapy
|
Shah, Shilpan
|
|
2014
|
14 |
S |
p. S127-
1 p.
|
artikel
|
| 79 |
Table of Contents
|
|
|
2014
|
14 |
S |
p. A7-A8
nvt p.
|
artikel
|
| 80 |
Targeting the Cell Cycle Regulated Cdc7 Kinase Pathway as a Novel Therapeutic Approach for Hematologic Malignancies
|
Santos, Ruth
|
|
2014
|
14 |
S |
p. S157-S158
2 p.
|
artikel
|
| 81 |
TET2 Mutations, Myelodysplastic Features, and a Distinct Immunoprofile Characterize Blastic Plasmacytoid Dendritic Cell Neoplasm in the Bone Marrow
|
Alayed, Khaled
|
|
2014
|
14 |
S |
p. S128-
1 p.
|
artikel
|
| 82 |
The Anti-Proliferative and Pro-apoptotic Effect of Topotecan in Combination With Thymoquinone in Acute Myelogenous Leukemia
|
Rizk, Sandra
|
|
2014
|
14 |
S |
p. S125-S126
2 p.
|
artikel
|
| 83 |
The Pharmacological Profiles of Approved Cytotoxic AML Treatments ex vivo Identifies Sensitive vs Resistant Treatments in Patient’s Leukemic Cells
|
Ballesteros, Joan
|
|
2014
|
14 |
S |
p. S117-
1 p.
|
artikel
|
| 84 |
The Proceedings of the Initial Meeting of the Society of Hematologic Oncology 2013
|
Freireich, Emil J.
|
|
2014
|
14 |
S |
p. S1-
1 p.
|
artikel
|
| 85 |
Therapy Related Cellular Changes as a Tool for Prognosis in AML
|
Benton, Chris
|
|
2014
|
14 |
S |
p. S120-
1 p.
|
artikel
|
| 86 |
The Road to Treating Smoldering Multiple Myeloma
|
Korde, Neha
|
|
2014
|
14 |
S |
p. S59-S64
6 p.
|
artikel
|
| 87 |
The Warburg Effect Confers Adverse Outcome in Chronic Lymphocytic Leukemia
|
Gardner, Jeffrey R.
|
|
2014
|
14 |
S |
p. S131-
1 p.
|
artikel
|
| 88 |
Thiamine Deficiency in Stem Cell Transplant Patients: A Case Series With an Accompanying Review of the Literature
|
Steinberg, Amir
|
|
2014
|
14 |
S |
p. S111-S113
3 p.
|
artikel
|
| 89 |
Toward Optimal Selection of Cellular Products for Hematology/Oncology Patients Eliminating Adverse Effects
|
Hashmi, Ghazala
|
|
2014
|
14 |
S |
p. S158-
1 p.
|
artikel
|
| 90 |
Transcriptional and Post-translational Regulation of the Bcl-2 Family by IL-6 Mediates Resistance to ABT-737 in Multiple Myeloma
|
Gupta, Vikas A.
|
|
2014
|
14 |
S |
p. S148-
1 p.
|
artikel
|
| 91 |
Use of Spleen as an Internal Marker in Whole Body DWIBS Exam in Patients of Multiple Myeloma
|
Kumar, Manoj
|
|
2014
|
14 |
S |
p. S148-
1 p.
|
artikel
|
Tijdschrift beschrijving